U.S. Stem Cell, Inc.
DelistedCIK 1388319fmd_1GQXPJ76GM05ZDSK86VK23GSQNServices · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Jan 01, 2000 to Dec 31, 2022, 61 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 2 | 2 | 3 | 6 | 7 | 3 | 0 | 0 | 0 |
| Cost of revenue | 0 | 1 | 1 | 1 | 2 | 2 | 1 | 0 | 0 | 0 |
| Gross profit | 0 | 1 | 1 | 2 | 4 | 5 | 2 | 0 | 0 | 0 |
| Research and development | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – |
| Selling, general and administrative | 2 | 5 | 4 | 3 | 4 | 6 | 4 | 3 | 2 | 2 |
| Total operating expenses | 3 | 5 | 4 | 3 | 4 | 6 | 5 | 3 | 2 | 2 |
| Operating income | (3) | (4) | (3) | (1) | (1) | (1) | (3) | (2) | (2) | (2) |
| Interest expense | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Interest and investment income | – | – | – | – | – | – | – | – | – | – |
| Other non-operating income (expense) | (0) | 1 | 1 | (1) | (3) | (1) | (0) | (0) | (1) | (1) |
| Income before taxes | (3) | (2) | (2) | (2) | (3) | (2) | (4) | (3) | (3) | (3) |
| Income tax expense | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | (2) | (2) | (2) | (3) | (2) | (4) | (3) | (3) | (3) |
| Net income | (3) | (2) | (2) | (2) | (3) | (2) | (4) | (3) | (3) | (3) |
| Net income to common shareholders | – | – | – | – | – | – | – | – | – | – |